My Blog List

Friday, 24 November 2017

Antibacterial Drug Resistance Market Analysis, Forecast, and Assessment 2022

Description:

In this report, the United States Antibacterial Drug Resistance market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Antibacterial Drug Resistance in these regions, from 2012 to 2022 (forecast).


United States Antibacterial Drug Resistance market competition by top manufacturers/players, with Antibacterial Drug Resistance sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
AAIPharma Services
ANTABIO
Abgentis
Abbott Laboratories
Absynth Biologics
Achaogen
Acino Holdings
Aventis Pharma
Austell Laboratories
Assembly Biosciences
Arpida
Demuris
Evolva Holding
ContraFect
Cerexa
GSK
InterMune
Isis Pharmaceuticals
Lyndra
Microbecide
Morphochem
Nabriva Therapeutics
NanoSafe Coatings
Novexel
Osel
PENDOPHARM
Pfizer
VenatoRx Pharmaceuticals


On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Telavancin (Vibativ)
Ceftaroline Fosamil (Teflaro/ Zinforo)
Fidaxomicin (Dificid / Dificlir)
Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
Dalbavancin (Dalvance/ Xydalba)
Tedizolid Phosphate (Sivextro)
Oritavancin (Orbactiv/ Nuvocid)
Ceftolozane-Tazobactam (Zerbaxa)
Ceftazidime-Avibactam (Avycaz/ Zavicefta)
PHASE III DRUGS
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibacterial Drug Resistance for each application, including
Gram-Positive
Gram-Negative

Make an Enquiry Of report for Discount @ https://www.reporthive.com/enquiry.php?id=1163082&req_type=disc

Table of Content:

1 Antibacterial Drug Resistance Overview1.1 Product Overview and Scope of Antibacterial Drug Resistance
1.2 Classification of Antibacterial Drug Resistance by Product Category
1.2.1 United States Antibacterial Drug Resistance Market Size (Sales Volume) Comparison by Type (2012–2022)
1.2.2 United States Antibacterial Drug Resistance Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Telavancin (Vibativ)
1.2.4 Ceftaroline Fosamil (Teflaro/ Zinforo)
1.2.5 Fidaxomicin (Dificid / Dificlir)
1.2.6 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
1.2.7 Dalbavancin (Dalvance/ Xydalba)
1.2.8 Tedizolid Phosphate (Sivextro)
1.2.9 Oritavancin (Orbactiv/ Nuvocid)
1.2.10 Ceftolozane-Tazobactam (Zerbaxa)
1.2.11 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
1.2.12 PHASE III DRUGS
1.3 United States Antibacterial Drug Resistance Market by Application/End Users
1.3.1 United States Antibacterial Drug Resistance Market Size (Consumption) and Market Share Comparison by Application (2012–2022)
1.3.2 Gram-Positive
1.3.3 Gram-Negative
1.4 United States Antibacterial Drug Resistance Market by Region
1.4.1 United States Antibacterial Drug Resistance Market Size (Value) Comparison by Region (2012–2022)
1.4.2 The West Antibacterial Drug Resistance Status and Prospect (2012–2022)
1.4.3 Southwest Antibacterial Drug Resistance Status and Prospect (2012–2022)
1.4.4 The Middle Atlantic Antibacterial Drug Resistance Status and Prospect (2012–2022)
1.4.5 New England Antibacterial Drug Resistance Status and Prospect (2012–2022)
1.4.6 The South Antibacterial Drug Resistance Status and Prospect (2012–2022)
1.4.7 The Midwest Antibacterial Drug Resistance Status and Prospect (2012–2022)
1.5 United States Market Size (Value and Volume) of Antibacterial Drug Resistance (2012–2022)
1.5.1 United States Antibacterial Drug Resistance Sales and Growth Rate (2012–2022)
1.5.2 United States Antibacterial Drug Resistance Revenue and Growth Rate (2012–2022)

2 United States Antibacterial Drug Resistance Market Competition by Players/Suppliers2.1 United States Antibacterial Drug Resistance Sales and Market Share of Key Players/Suppliers (2012–2017)
2.2 United States Antibacterial Drug Resistance Revenue and Share by Players/Suppliers (2012–2017)
2.3 United States Antibacterial Drug Resistance Average Price by Players/Suppliers (2012–2017)
2.4 United States Antibacterial Drug Resistance Market Competitive Situation and Trends
2.4.1 United States Antibacterial Drug Resistance Market Concentration Rate
2.4.2 United States Antibacterial Drug Resistance Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antibacterial Drug Resistance Manufacturing Base Distribution, Sales Area, Product Type

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014,
India